NCT03360162

Completed

Velocimetric Study of Temporal Arteries in Patients With Hor...

University Hospital, Brest Source

Compare

Other study identifiers

Sponsor study identifier

VELHOR ( 29BRC17.0227)

Study Type

observational

Actual enrollment (reported)

46

Locations

1 country

Sites

1

Timeline

Study Start

November 2, 2017

Actual (reported)

Primary Completion

December 10, 2017

Actual (reported)

Study Completion

December 10, 2017

Actual (reported)

Brief Summary

The use of ultrasonography in detecting giant cell arteritis ( GCA) is emerging. Currently, temporal biopsy is the gold standard to diagnose GCA but studies have shown the interest to use B mode ultrasonography. However, until now, the study of velocities in GCA have not been yet performed.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 46 participants
Study completion date: December 10, 2017
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
November 2, 2017
Actual (reported)
First Submitted
November 28, 2017
Actual (reported)
First Posted
December 4, 2017
Actual (reported)
Primary Completion
December 10, 2017
Actual (reported)
Study Completion
December 10, 2017
Actual (reported)

Last Updated: April 21, 2020
Status Verified: April 2020
Last Update Submitted: April 20, 2020

Conditions

Horton Disease

Outcome Measures

Primary Outcomes (1)

Velocimetric Study of Temporal Arteries in Patients With Horton Disease Using Scan-Doppler
velocimetric temporal arterial study in giant arteritis
2 months

Secondary Outcomes (1)

evaluation of the halo sign in giant arteritis using B mode ultrasonography
2 months

Eligibility Criteria

Age55 Years+

Sexall

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodProbability Sample

Study Population

all patients aged more than 55 years old who are suspected of giant arteritis

You may qualify if:

patients with suspicious giant arteritis

You may not qualify if:

Sponsors & Collaborators

University Hospital, Brest
Otherlead

Study Sites (1)

CHRU de Brest

Brest, 29609, France

MeSH Terms

Conditions

Giant Cell Arteritis

Condition Hierarchy (Ancestors)

Vasculitis, Central Nervous SystemAutoimmune Diseases of the Nervous SystemNervous System DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesVascular DiseasesCardiovascular DiseasesArteritisVasculitisSkin Diseases, VascularSkin DiseasesSkin and Connective Tissue DiseasesAutoimmune Diseases

Enrollment

46 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: RETROSPECTIVE
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

November 28, 2017

First Posted

December 4, 2017

Study Start

November 2, 2017

Actual (reported)

NCT05246540

Evaluation of PET/CT of Cephalic Arteries for the Diagnosis of Giant Cell Arteritis

Completed

NCT02703922

Validation of a Diagnostic Algorithm of Giant Cell Arteritis

Not ApplicableCompleted

NCT06894602

Association of Ultrasonographic Temporal Artery Lesions and Relapse in Patients With Giant Cell Arteritis

Recruiting

NCT02857192

Study of Phenotypic and Functional Characteristics of Regulatory T Lymphocytes in Horton's Disease

Not ApplicableCompleted

NCT02902731

Giant Cell Arteritis and Anakinra Trial

Phase 3Terminated

NCT04010097

Chewing Gum Test for the Diagnosis of Giant Cell Arteritis (Horton's Disease) - ChewingHort

Not ApplicableCompleted

patients who have already been treated or diagnosed for giant arteritis

Contact the study team to confirm eligibility.

Immune System Diseases

Primary Completion

December 10, 2017

Actual (reported)

Study Completion

December 10, 2017

Actual (reported)

Last Updated

April 21, 2020

Record last verified: 2020-04

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT03360162
Data provider: ClinicalTrials.gov
Source updated: 2020-04-21
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:27:44 UTC

Locations

FR(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Enrollment

Study Design

Study Record Dates

Source record

Locations